The Oligonucleotide Synthesis Market is poised for robust growth, fueled by advancements in personalized medicine, molecular diagnostics, and genomics research. However, high production costs ...

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a new study.

The Trump administration has delivered its latest blow to vaccines, canceling a nearly $600-million contract to the drugmaker Moderna that was intended to develop a shot for humans against bird flu.

But even though these firsts took place during the pandemic, mRNA vaccines had been in development for many years before COVID-19 emerged as a threat.. Looking forward, they'll likely continue to ...

Engineered mRNA has turned cells into tiny biofactories, producing medications to successfully treat an inflammatory skin condition and two types of cancer, according to a new study. The tech ...

But the self-amplifying mRNA shot did elicit antibodies in a greater percentage of people than Comirnaty. And a month out, antibody levels against Omicron BA.4/5 were higher in people who received ...

Overall, 35,541 participants were assigned to receive the mRNA-1345 vaccine (17,793 participants) or placebo (17,748). The median follow-up was 112 days (range, 1 to 379).

These mRNA vaccines demonstrate the flexibility of mRNA-based therapies. As the virus that causes COVID-19 mutates, new viral variants can evade existing antibodies and cause new waves of illness.

COVID vaccines have shown us the potential of mRNA technology. Siyanight/Shutterstock. This paved the way for mRNA COVID vaccines which instruct our cells to make spike proteins, proteins on the ...

Scientists hope to leverage mRNA for a bevy of vaccines and therapeutics. Hello again from The Checkup! This week the Nobel Committee for Physiology or Medicine honored two scientists whose ...